| ★ | Whitepaper: Accelerating access: Expedited and harmonised pathways for innovative therapies | | 19 | Irlanda | |
| 3 | Streamline the Drug Development Pipeline - Accelerating Innovation in Healthcare | BioTech Whisperer @biotechwhisperer | 4.0K | Estados Unidos | 89 |
| 14 | Molecular Pathways in Cancer Targeted Therapies Explained | BioTech Whisperer @biotechwhisperer | 677 | Estados Unidos | 86 |
| 10 | Rewriting the Rules: Scaling Innovation for Rare Diseases | Global Conference 2026 | Milken Institute @milkeninstitute | 497 | Estados Unidos | 86 |
| 9 | Understanding the FDA's Plausible Mechanism Framework | National Organization for Rare Disorders (NORD) @raredisorders | 276 | Estados Unidos | 86 |
| 20 | Accelerating Drug Discovery with AI | Iktos | AWS Pioneers Project | Amazon Web Services @amazonwebservices | 248 | Estados Unidos | 85 |
| 19 | Understanding the Drug Development Pipeline (9 Minutes) | BioTech Whisperer @biotechwhisperer | 232 | Estados Unidos | 85 |
| 11 | How Regor Therapeutics Uses AI to Accelerate Drug Discovery | WebsEdgeMedicine @websedgemedicine | 139 | — | 86 |
| 6 | Leveraging Innovative Trial Designs and Technologies to Accelerate - NORD Scientific Symposium | National Organization for Rare Disorders (NORD) @raredisorders | 129 | Estados Unidos | 87 |
| 15 | Whitepaper: Survey results: How to engage healthcare decision-makers | | 114 | Irlanda | 86 |
| 1 | Regulatory Affairs overview | | 57 | Irlanda | 90 |
| 8 | Personalized Cancer Treatment - Molecular Pathways in Cancer Targeted Therapies in Action (10 Mins) | BioTech Whisperer @biotechwhisperer | 48 | Estados Unidos | 87 |
| 7 | Whitepaper: ICON ICH GCP implementation | | 41 | Irlanda | 87 |
| 4 | Whitepaper: Making sense of the rapidly changing biosimilars landscape | | 38 | Irlanda | 88 |
| 17 | Matt Kropp on “How Can AI Accelerate Progress in the Bio World?” | Reinvent Futures @reinventfutures | 33 | Estados Unidos | 86 |
| 2 | Whitepaper: Procedural and regulatory know how for China biotech in the EU | | 23 | Irlanda | 89 |
| 5 | Whitepaper: The future of oncology biosimilars: Considerations for development through 2040 | | 22 | Irlanda | 88 |
| 18 | Regulatory Landscapes Across the World - FDA and EMA Guidelines (11 Minutes) | Microlearning Daily @microlearningdaily | 10 | Singapur | 85 |
| 13 | Repurposed Drugs: The Shortest Path to a Cure #health #education #bodybuilding #medical #medicine | UFO FILES DECLASSIFIED @vipersshorts | 3 | Estados Unidos | 86 |
| 12 | Why Is Equitable Access Critical In Genetic Therapies? | Everyday Bioethics Expert @everydaybioethicsexpert | 1 | Estados Unidos | 86 |
| 16 | Regulatory Challenges and Opportunities for Digital Therapeutics | Gyan Solutions @gyan_solutions | 0 | Canadá | 86 |